Showing results (1201-1210 of 5,142) with videos related to

Sort By:
Pageof 515
The Journal of Infection|March 3, 2024
Current state of COVID-19 in children: 4 years onAnnabel A Powell, Alexander C Dowell, Paul Moss, et al.
The Journal of Infection|October 6, 2023
Routine, molecular point-of-care testing for SARS-CoV-2 and other respiratory viruses within an acute oncology service improves patient careKate R Beard, Florina Borca, Hang Phan, et al.
The Journal of Infection|July 19, 2023
Artificial intelligence, machine learning and deep learning: Potential resources for the infection clinicianAnastasia A Theodosiou, Robert C Read
The Journal of Infection|July 5, 2023
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trialChristian Taucher, Rajeka Lazarus, Hanna Dellago, et al.
The Journal of Infection|August 21, 2023
Evaluation of the contribution of shotgun metagenomics in the microbiological diagnosis of liver abscessesHadrien Kimseng, Geoffrey Rossi, Maxime Danjean, et al.
The Journal of Infection|September 27, 2023
Effect of dexamethasone dose on outcomes in acute COVID-19 disease: A systematic review and meta-analysisTimothy Arthur Chandos Snow, Nishkantha Arulkumaran, Mervyn Singer, et al.
The Journal of Infection|June 27, 2023
Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in a remote region of NigerHervé Jacquier, Bachir Assao, Françoise Chau, et al.
The Journal of Infection|September 10, 2023
Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trialSady A Alpizar, Jose Accini, Duane C Anderson, et al.
The Journal of Infection|June 15, 2023
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patientsBenedict Fallet, Mathilde Foglierini, Raphael Porret, et al.
The Journal of Infection|March 16, 2026
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in AustraliaNadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
Pageof 515